FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to using herbal products, to medicine and pharmacology, namely to reduce the mutagenic effect of the anti-drug preparation. What is presented is the use of miliacin as an agent which reduces the mutagenic effect of cyclophosphan.
EFFECT: invention provides limiting by-effects of chemotherapy.
1 cl, 5 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| AGENT FOR REDUCING SYSTEMIC PATHOLOGIC ENDOTOXINEMIA | 2014 | 
 | RU2564918C1 | 
| AGENT LIMITING LYMPHOTOXIN EFFECT OF METHOTREXATE | 2007 | 
 | RU2337693C1 | 
| METHOD OF PROTECTING POST-VACCINATION IMMUNITY TO TETANUS ANATOXIN AGAINST METHOTREXATE-INDUCED DEPRESSION | 2008 | 
 | RU2394577C1 | 
| METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 | 
 | RU2504392C1 | 
| ANTIMUTAGENIC AGENT | 2000 | 
 | RU2189232C2 | 
| METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 | 
 | RU2261704C2 | 
| METHOD FOR REDUCING GEMOTOXIC ACTION OF BENZENE ON AN ORGANISM | 2017 | 
 | RU2724891C2 | 
| MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 | 
 | RU2411947C1 | 
| AGENT ENHANCING IMMUNOGENIC PROPERTY OF TETANUS ANATOXIN | 2003 | 
 | RU2244548C1 | 
| METHOD FOR COMPLEX CORRECTION OF NON-SCARRING ALOPECIA IN EXPERIMENT | 2023 | 
 | RU2821779C1 | 
Authors
Dates
2019-08-23—Published
2019-04-17—Filed